Boyd Associates, Inc., a third party consulting firm, is currently recruiting patients for an internet survey regarding issues the Glanzmann’s Thrombasthenia (GT) Community faces, on behalf of a pharmaceutical company. Glanzmann’s Thrombasthenia (GT) is a rare platelet disorder, where bleeding is significantly prolonged because of defective/low levels of glycoprotein. If you are an adult patient with GT or the parent of one or more children (<18 years old) with GT interested in participating in this research, please send an email to boydinc@comcast.net to receive an invitation and instructions for completing the survey. An honorarium will be offered for participation and any information you provide is strictly confidential.
Topic Author